These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6259821)

  • 1. Search for specific DNAs in Creutzfeldt-Jakob infectious brain fractions using "nick translation".
    Manuelidis L; Manuelidis EE
    Virology; 1981 Mar; 109(2):435-43. PubMed ID: 6259821
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.
    Sklaviadis T; Dreyer R; Manuelidis L
    Virus Res; 1992 Dec; 26(3):241-54. PubMed ID: 1492497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.
    Brown P; Rohwer RG; Gajdusek DC
    J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Creutzfeld-Jakob disease: recent advances; biology of unconventional viruses (author's transl)].
    Cathala F; Moreau-Dubois MC; Brown P
    Pathol Biol (Paris); 1980 Oct; 28(8):545-53. PubMed ID: 6776473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease.
    Mori S; Hamada C; Kumanishi T; Fukuhara N; Ichihashi Y; Ikuta F; Miyatake T; Tsubaki T
    Neurology; 1989 Oct; 39(10):1337-42. PubMed ID: 2677833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical properties of the Creutzfeldt-Jakob disease agent.
    Sklaviadis TK; Manuelidis L; Manuelidis EE
    J Virol; 1989 Mar; 63(3):1212-22. PubMed ID: 2492609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis.
    Dron M; Manuelidis L
    J Neurovirol; 1996 Aug; 2(4):240-8. PubMed ID: 8799215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viremia in experimental Creutzfeldt-Jakob disease.
    Manuelidis EE; Gorgacs EJ; Manuelidis L
    Science; 1978 Jun; 200(4345):1069-71. PubMed ID: 349691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease with demonstration of virus-like particles.
    Shibayama Y; Sakaguchi Y; Nakata K; Goto T; Nakai M; Takai T; Shirakata S
    Acta Pathol Jpn; 1982 Jul; 32(4):695-702. PubMed ID: 7051752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrapie and Creutzfeldt-Jakob disease prions.
    Prusiner SB; Barry RA; McKinley MP; Bellinger CG; Meyer RK; DeArmond SJ; Kingsbury DT
    Microbiol Sci; 1985; 2(2):33-9. PubMed ID: 3940147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.
    Manuelidis EE; Fritch WW; Kim JH; Manuelidis L
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):871-5. PubMed ID: 3543937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease.
    Vernon ML; Horta-Barbosa L; Fuccillo DA; Sever JL; Baringer JR; Birnbaum G
    Lancet; 1970 May; 1(7654):964-6. PubMed ID: 4191933
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease.
    Connolly JH; Allen IV; Dermott E
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1459-60. PubMed ID: 3069961
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-conventional central nervous system agents].
    Chippaux A
    Bull Soc Pathol Exot Filiales; 1987; 80(5):727-36. PubMed ID: 2897253
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity.
    Taylor DM
    Neuropathol Appl Neurobiol; 1989; 15(6):585-6. PubMed ID: 2693993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.